REVIEW J Am Soc Nephrol 14: 2402–2410, 2003

Total Page:16

File Type:pdf, Size:1020Kb

REVIEW J Am Soc Nephrol 14: 2402–2410, 2003 REVIEW J Am Soc Nephrol 14: 2402–2410, 2003 Memory T Cells: A Hurdle to Immunologic Tolerance FADI G. LAKKIS* and MOHAMED H. SAYEGH† *Section of Nephrology, Department of Internal Medicine, and Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut; and †Renal Division, Brigham and Women’s Hospital, and Nephrology Division, Children’s Hospital, Harvard Medical School, Boston, Massachusetts. The induction of immunologic tolerance is an important Immunobiology of Memory T Cells clinical goal in transplantation and autoimmunity. Immuno- Upon exposure to a foreign antigen, antigen-specific T logic tolerance is traditionally defined as specific unrespon- cells proliferate (the expansion phase) and differentiate into siveness to a self- or foreign antigen while maintaining reac- effectors that eliminate the foreign intruder (Figure 1). The tivity to other (third party) antigens (1,2). In the context of vast majority of effector T cells, however, undergo apopto- transplantation, a tolerant patient is someone who is capable of sis as the immune response progresses (the death phase), mounting an effective immune response to vaccines and mi- and the few lymphocytes that survive become long-lived crobial pathogens but is incapable of rejecting the transplanted memory T cells (the memory phase) (8,9). Memory T cells organ. Similarly, induction of tolerance to an antigen that that recognize microbial antigens provide the organism with incites self-reactivity would ensure that the patient is free of long-lasting protection against potentially fatal infections. autoimmune manifestations in the absence of global and harm- Conversely, memory T cells that recognize donor alloanti- ful immunosuppression. Although several immunomodulatory gens jeopardize the survival of life-saving organ transplants strategies have been used successfully to induce immunologic by mediating rejection (10). Therefore, the central question in the pursuit of transplantation tolerance is how to coerce tolerance in rodents, the same strategies have failed in larger an immune response determined to generate T cell memory animals and in humans. Examples of induced tolerance in into a state of antigen-specific unresponsiveness. To begin organ transplant recipients or in patients with autoimmune to answer this question, we first highlight the general char- disease have been rare and often unintentional (3–6). acteristics of memory T cells that distinguish them from Why, then, has clinical tolerance been such an elusive goal? naïve T cells. Second, we summarize what is known about The answer to this question most likely lies in the immunologic the generation, maintenance, and activation (recall) of mem- barriers that preclude the induction of antigen-specific unre- ory T cells. sponsiveness in the adult animal (1,2). These barriers include the limitations of peripheral (extrathymic) immunoregulatory Memory Advantage mechanisms that are commonly exploited to induce tolerance Memory T cells have over their naïve counterparts several (T cell deletion, suppression, deviation, and anergy), the large inherent advantages that endow them with the ability to clear a repertoire of alloreactive T cells in the case of transplantation, foreign antigen, whether a microbial pathogen or an allograft, the uncertain nature of the pathogenic antigen in many auto- in a vigorous manner (Table 1). The first advantage that immune diseases, and the unavoidable fact that the adaptive memory T cells have is that their response to a foreign antigen immune response, by virtue of evolutionary design, is destined (recall response) is greater in magnitude and faster than the to generate immunologic memory. It is the last barrier that is naïve T cell response. Memory T cells generate a considerable perhaps the most important obstacle to immunologic tolerance. number of effector T cells, capable of cytokine secretion and/or Here, we address this thesis by reviewing the immunobiology cytolytic activity, within hours of antigenic restimulation, of memory T cells and their impact on solid organ transplan- whereas naïve T cells generate a smaller number of effectors tation. The same concepts that apply to understanding and and at a much slower pace (days) (11–14). Second, memory T controlling memory T cells in the context of transplantation are cells have a survival advantage over their naïve counterparts also relevant to autoimmunity (7). (15,16). Antigen-specific memory T cell populations persist for years to a lifetime in humans, and their survival seems to be antigen and MHC independent (17–19). Mature naïve T cell populations also persist for a relatively long period of time (months to a few years in humans), but their survival is Correspondence to Dr. Fadi G. Lakkis, Section of Nephrology, 333 Cedar Street, P.O. Box 208029, New Haven, CT 06520-8029. Phone: 203-737-2619; dependent on constant, low-grade stimulation with MHC–self- Fax: 203-737-1810; E-mail: [email protected] peptide complexes (20–22). Third, the circulation of naïve T 1046-6673/1409-2402 cells is restricted to secondary lymphoid tissues, the site where Journal of the American Society of Nephrology they are activated by foreign antigens presented by antigen- Copyright © 2003 by the American Society of Nephrology presenting cells (APC), whereas memory T cells circulate DOI: 10.1097/01.ASN.0000085020.78117.70 through both secondary lymphoid tissues and peripheral non- J Am Soc Nephrol 14: 2402–2410, 2003 Memory T Cells 2403 Figure 1. Foreign antigen triggers the proliferation of antigen-specific T cells (the expansion phase) and their differentiation into effectors. The vast majority of effector T cells undergo apoptosis (the death phase) as the foreign antigen is eliminated, and the few lymphocytes that survive become long-lived memory T cells (the memory phase). Immunologic tolerance can perhaps be viewed as the demise of antigen-specific memory lymphocytes or their precursors (red arrows). Table 1. Advantages of memory T cells over naı¨ve and effector T cellsa Characteristic Naı¨ve T Cell Effector T Cell Memory T Cell Survival Months to years Hours to days Years to lifetime Dependent on TCR Ag persistence leads Not dependent on TCR interaction with MHC/Ag to AICD interaction with MHC/Ag Migration Secondary lymphoid tissues Nonlymphoid tissues Both lymphoid and nonlymphoid tissues Response and effector Requires stimulation with Immediate Requires restimulation with function Ag Ag but is faster and larger in magnitude than naı¨ve T cells In vivo protection against Long-lived but relatively Short-lived but very Long-lived and efficient foreign Ag inefficient efficient a AICD, activation-induced cell death; Ag, antigen; TCR, T cell receptor for antigen. lymphoid tissues (23–25). Unlike naïve T cells, memory T pated. An antigen-experienced animal will eliminate the for- cells can directly encounter foreign antigen and mount a pro- eign antigen, whether a virus or an allograft, more efficiently ductive immune response within nonlymphoid tissues (25). than a naïve animal. The migratory advantage of memory T cells, therefore, allows them to detect and eliminate a foreign intruder long before it Generation of Memory T Cells reaches secondary lymphoid tissues. In summary, the activa- Antigenic stimulation of naïve T cells is a prerequisite for tion, survival, and migration advantages of memory T cells memory generation (26,27). It is also established that the confer the organism with enhanced protection against foreign magnitude of the expansion phase (burst size) of the primary antigens long after the primary immune response has dissi- immune response determines the size of the memory T cell 2404 Journal of the American Society of Nephrology J Am Soc Nephrol 14: 2402–2410, 2003 pool (28,29). Vaccination strategies that enhance T cell acti- naïve T cells that received suboptimal antigenic stimulation vation and proliferation by using strong adjuvants lead to larger and failed to proliferate. Importantly, it is not known how memory T cell populations. Because adjuvants directly influ- activated/effector T cells transition to the memory phenotype ence APC maturation and function, it is generally believed that (which is relatively quiescent and resembles that of a naïve T factors that stimulate the innate immune response, for example cell) and whether this transition is a stochastic process or an by inducing IFN-1 production or engaging Toll-like receptors instructional one (51). on APC (30,31), result in stronger adaptive immune responses Finally, recent studies propose the existence of two subsets and, subsequently, more memory T cells. Allografts are potent of CD4ϩ and CD8ϩ memory T cells based on the expression adjuvants as they contain their own APC and are subjected to of the homing receptors CC-chemokine receptor 7 (CCR7) and ischemia-reperfusion injury at the time of transplantation, L-selectin (CD62L) (56). The CCR7ϩ CD62Lhi “central” Ϫ lo which leads to activation of the innate immune system (32). In memory T cells (TCM) and CCR7 CD62L “effector” mem- fact, signaling via Toll-like receptors on graft dendritic cells ory T cells (TEM) have distinct migratory and functional char- plays an important role in initiating the alloimmune response acteristics (56–58). TCM circulate through secondary lymphoid ␥ (33). Therefore, it should not come as a surprise that transplant tissues, produce IL-2 but little IFN- and no perforin. TEM recipients harbor significant numbers of alloreactive memory T circulate through nonlymphoid peripheral tissues and produce and B cells. IFN-␥, perforin, and IL-4 but little IL-2. It has been proposed Because optimal T cell activation and proliferation require that the secondary lymphoid tissue resident TCM are responsi- the presence of adequate T cell co-stimulation, several co- ble for replenishing the memory T cell pool because of their stimulatory molecule pairs contribute to the generation of increased proliferative capacity, whereas the nonlymphoid tis- ϩ memory T cells. CD4 T cell proliferation and memory gen- sue resident TEM mediate effector functions and rapid elimi- eration are significantly impaired but not completely absent in nation of antigen (23,24,56).
Recommended publications
  • The TNF-Family Cytokine TL1A Drives IL-13-Dependent Small Intestinal Inflammation
    ARTICLES nature publishing group See ARTICLE page 186 The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation F M e y l a n 1 , 6 , Y - J S o n g 1 , 6 , I F u s s 2 , S V i l l a r r e a l 1 , E K a h l e 1 , I - J M a l m 1 , K A c h a r y a 1 , H L R a m o s 3 , L L o 4 , M M M e n t i n k - K a n e 5 , T A W y n n 5 , T - S M i g o n e 4 , W S t r o b e r 2 a n d R M S i e g e l 1 The tumor necrosis factor (TNF)-family cytokine TL1A (TNFSF15) costimulates T cells through its receptor DR3 (TNFRSF25) and is required for autoimmune pathology driven by diverse T-cell subsets. TL1A has been linked to human inflammatory bowel disease (IBD), but its pathogenic role is not known. We generated transgenic mice that constitutively express TL1A in T cells or dendritic cells. These mice spontaneously develop IL-13-dependent inflammatory small bowel pathology that strikingly resembles the intestinal response to nematode infections. These changes were dependent on the presence of a polyclonal T-cell receptor (TCR) repertoire, suggesting that they are driven by components in the intestinal flora. Forkhead box P3 (FoxP3)-positive regulatory T cells (Tregs) were present in increased numbers despite the fact that TL1A suppresses the generation of inducible Tregs.
    [Show full text]
  • Effector CD4 T-Cell Transition to Memory Requires Late Cognate Interactions That Induce Autocrine IL-2
    ARTICLE Received 3 Jun 2014 | Accepted 24 Sep 2014 | Published 5 Nov 2014 DOI: 10.1038/ncomms6377 Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2 K. Kai McKinstry1,*, Tara M. Strutt1,*, Bianca Bautista1, Wenliang Zhang1, Yi Kuang1, Andrea M. Cooper2 & Susan L. Swain1 It is unclear how CD4 T-cell memory formation is regulated following pathogen challenge, and when critical mechanisms act to determine effector T-cell fate. Here, we report that following influenza infection most effectors require signals from major histocompatibility complex class II molecules and CD70 during a late window well after initial priming to become memory. During this timeframe, effector cells must produce IL-2 or be exposed to high levels of paracrine or exogenously added IL-2 to survive an otherwise rapid default contraction phase. Late IL-2 promotes survival through acute downregulation of apoptotic pathways in effector T cells and by permanently upregulating their IL-7 receptor expression, enabling IL-7 to sustain them as memory T cells. This new paradigm defines a late checkpoint during the effector phase at which cognate interactions direct CD4 T-cell memory generation. 1 Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655, USA. 2 Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, New York 12983, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to K.K.M. (email: [email protected]). NATURE COMMUNICATIONS | 5:5377 | DOI: 10.1038/ncomms6377 | www.nature.com/naturecommunications 1 & 2014 Macmillan Publishers Limited.
    [Show full text]
  • Immunity ≠ Immunological Memory
    Immunity ≠ Immunological Memory Rolf Zinkernagel University of Zurich IMI Stakeholder Forum - 13 May 2013 - Brussels • Protective vaccines imitate co-evolution of infectious agents and hosts. • We cannot do better than evolution by using the same tools, only when introducing ‘new’ tools (antibiotics, antivirals, autoantibodies, behavioural changes) • Vaccines against solid tumours (carcinomas, sarcomas) and chronic persistent infections are theoretically not impossible but practically highly unlikely! Vaccines Not successful available Polio 1, 2, 3 TB bact. toxins Leprosy measles HIV Haem. infl. malaria (cholera) Neutr. / effector T cells opsonising antibodies antibodies igG (IgA) IMMUNITY • "innate resistance" > 95 % • Ab in eggs • protective memory via Ab (vaccines) • TB: no vaccine • autoimmunity > 30 y, female > male 5 : 1 • tumors > 30 years • Is what we measure biologically important ? (e.g. acad. memory: earlier + greater) CTL ELISA nAb Immunity Immunology Protection • ‚Memory‘ • Small pox • quicker - higher • Poliomeningitis • Measles • HIV, malaria - • Tuberculosis ± Antibody Memory after immunization with VSV a) neutralizing antibodies b) ELISA 12 12 ) 10 ) 10 2 3 8 8 40 log 10 log 6 - - 6 NP binding NP - 4 IND neutralizing 4 - IgG ( IgG ( 2 VSV 2 VSV 0 0 0 20 100 200 300 0 20 100 200 300 days after immunization days after immunization Why immunological Memory ? Protection (immunity) counts ! • Earlier + better • If first infection survived no need for memory • If first infection kills no need for memory • All vaccines that
    [Show full text]
  • Memory T Cells + Maintenance of CD8 the Dual Role of IL-2 in the Generation
    The Dual Role of IL-2 in the Generation and Maintenance of CD8 + Memory T Cells Zhenhua Dai, Bogumila T. Konieczny and Fadi G. Lakkis This information is current as J Immunol 2000; 165:3031-3036; ; of September 30, 2021. doi: 10.4049/jimmunol.165.6.3031 http://www.jimmunol.org/content/165/6/3031 Downloaded from References This article cites 31 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/165/6/3031.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 30, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Dual Role of IL-2 in the Generation and Maintenance of CD8؉ Memory T Cells1 Zhenhua Dai, Bogumila T. Konieczny, and Fadi G. Lakkis2 The mechanisms responsible for the generation and maintenance of T cell memory are unclear. In this study, we tested the role of IL-2 in allospecific CD8؉ T cell memory by analyzing the long-term survival, phenotype, and functional characteristics of IL-2-replete (IL-2؉/؉) and IL-2-deficient (IL-2؊/؊) CD8؉ TCR-transgenic lymphocytes in an adoptive transfer model.
    [Show full text]
  • Lymphopenia-Induced Proliferation Lymphocytes During and After
    The Journal of Immunology Effects of Increasing IL-7 Availability on Lymphocytes during and after Lymphopenia-Induced Proliferation1 Nabil Bosco,* Fabien Agene`s,* and Rhodri Ceredig2† IL-7 is critically involved in regulating peripheral T cell homeostasis. To investigate the role of IL-7 on lymphopenia-induced proliferation of polyclonal lymphocytes, we have transferred CFSE-labeled cells into a novel T-lymphopenic, IL-7-transgenic mouse line. Results obtained indicate that T and B cells do not respond in the same way to IL-7-homeostatic signals. Overex- pression of IL-7 enhances proliferation of both CD4؉ and CD8؉ T cells but with distinctly temporal effects. Expansion of naturally arising CD4؉-regulatory T cells was like that of conventional CD4؉ T cells. IL-7 had no effect on B cell proliferation. By immunohistology, transferred T cells homed to T cell areas of spleen lymphoid follicles. Increasing IL-7 availability enhanced T cell recovery by promoting cell proliferation and reducing apoptosis during early stages of lymphopenia-induced proliferation. Taken together, these results provide new insights into the pleiotropic effects of IL-7 on lymphopenia-induced T cell proliferation. The Journal of Immunology, 2005, 175: 162–170. espite declining thymic output with age, the peripheral T either IL-7-deficient or wild-type mice treated with anti-IL-7 or cell pool of an adult animal remains remarkably stable anti-IL-7R␣ mAb show that perturbation of IL-7 signals prevents D (1, 2). How the T cell pool is maintained remains a cen- the expansion of transferred T cells (1, 10).
    [Show full text]
  • Module 3: Development of Immune Cells
    NPTEL – Biotechnology – Cellular and Molecular Immunology Module 3: Development of immune cells Lecture 15: Development of Lymphocytes (Part I) Pluripotent stem cells and fetal liver are considered as hematopoietic stem cells in the body which give rise to lineages of blood cells. Hematopoietic stem cells also differentiate into B cells, T cells, and antigen presenting cells following maturation. The maturation of B cells mostly occurs in the fetal liver before birth and in the bone marrow after birth. The T cells form in the liver before birth and complete maturation in thymus after birth. The most common form of T cells i.e αβ T cells develop in the bone marrow while less common form γδ T cells develop in neonatal liver. The differentiation of B and T lymphocytes from precursor stem cells largely depends on the signals induced by the surface receptors present over the hematopoietic stem cells which induce different transcriptional factors involved in its maturation. 15.1 Differentiation of B and T lymphocytes from progenitor cells 15.1.1 B cells differentiation Pluripotent hematopoietic stem cells differentiate into B cells under the influence of transcription factors E2A, EBF, and Pax5. These transcription factor works synergistically to induce the transcription of specific genes and their recombination responsible for the development of B lymphocytes. Pluripotent hematopoietic stem cells are differentiated into Pro-B cells which give rise to follicle B cells, marginal B cells, and B-1 B cells. 15.1.2 T cell differentiation Pluripotent hematopoietic stem cells first give rise to common lymphoid progenitor cells. The common lymphoid progenitor cells can either give rise to natural killer cells or Pro-T cells under the influence of different transcriptional factors.
    [Show full text]
  • CD8 Naive T Cell Counts Decrease Progressively in HIV-Infected Adults
    CD8 naive T cell counts decrease progressively in HIV-infected adults. M Roederer, … , L A Herzenberg, L A Herzenberg J Clin Invest. 1995;95(5):2061-2066. https://doi.org/10.1172/JCI117892. Research Article We show here that CD8 naive T cells are depleted during the asymptomatic stage of HIV infection. Although overall CD8 T cell numbers are increased during this stage, the naive CD8 T cells are progressively lost and fall in parallel with overall CD4 T cell counts. In addition, we show that naive CD4 T cells are preferentially lost as total CD4 cell counts fall. These findings, presented here for adults, and in the accompanying study for children, represent the first demonstration that HIV disease involves the loss of both CD4 T cells and CD8 T cells. Furthermore, they provide a new insight into the mechanisms underlying the immunodeficiency of HIV-infected individuals, since naive T cells are required for all new T cell-mediated immune responses. Studies presented here also show that the well-known increase in total CD8 counts in most HIV-infected individuals is primarily due to an expansion of memory cells. Thus, memory CD8 T cells comprise over 80% of the T cells in PBMC from individuals with < 200 CD4/microliter, whereas they comprise roughly 15% in uninfected individuals. Since the naive and memory subsets have very different functional activities, this altered naive/memory T cell representation has significant consequences for the interpretation of data from in vitro functional studies. Find the latest version: https://jci.me/117892/pdf CD8 Naive T Cell Counts Decrease Progressively in HIV-infected Adults Mario Roederer, J.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • NK Cells Remember
    Sweet Is the Memory of Past Troubles: NK Cells Remember Deborah W. Hendricks, Gundula Min-Oo and Lewis L. Lanier Abstract Natural killer (NK) cells are important in host defense against tumors and microbial pathogens. Recent studies indicate that NK cells share many features with the adaptive immune system, and like B cells and T cells, NK cells can acquire immunological memory. Here, we review evidence for NK cell memory and the molecules involved in the generation and maintenance of these self-renewing NK cells that provide enhanced protection of the host. Contents 1 Introduction.............................................................................................................................. 2 Antigen-Specific Recall Responses in a Contact Hypersensitivity Model............................. 2.1 Hepatic NK Cells Acquire Memory to Haptens and Viruslike Particles ...................... 2.2 Insights into the Mechanism of NK Cell Memory in Contact Hypersensitivity and Skin Inflammation ................................................................................................... 3 The Development of NK Cell Memory in Chronic Viral Infections..................................... 3.1 NK Cell Memory Following Mouse Cytomegalovirus Infection .................................. 3.2 NK Cell Memory Following Human Cytomegalovirus Infection ................................. 3.3 Antibody-Dependent Memory-Like NK Cells ............................................................... 3.4 Specificity of NK Cell Memory in Mice and Humans.................................................
    [Show full text]
  • The Anatomy of T-Cell Activation and Tolerance Anna Mondino*T, Alexander Khoruts*, and Marc K
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2245-2252, March 1996 Review The anatomy of T-cell activation and tolerance Anna Mondino*t, Alexander Khoruts*, and Marc K. Jenkins Department of Microbiology and the Center for Immunology, University of Minnesota Medical School, 420 Delaware Street S.E, Minneapolis, MN 55455 ABSTRACT The mammalian im- In recent years, it has become clear that TCR is specific for a self peptide-class I mune system must specifically recognize a full understanding of immune tolerance MHC complex) T cell that will exit the and eliminate foreign invaders but refrain cannot be achieved with reductionist in thymus and seed the secondary lymphoid from damaging the host. This task is vitro approaches that separate the individ- tissues (3, 4). In contrast, cortical CD4+ accomplished in part by the production of ual lymphocyte from its in vivo environ- CD8+ thymocytes that express TCRs that a large number of T lymphocytes, each ment. The in vivo immune response is a have no avidity for self peptide-MHC bearing a different antigen receptor to well-organized process that involves mul- complexes do not survive and die by an match the enormous variety of antigens tiple interactions of lymphocytes with each apoptotic mechanism. Cortical epithelial present in the microbial world. However, other, with bone-marrow-derived antigen- cells are essential for the process of pos- because antigen receptor diversity is gen- presenting cells (APCs), as well as with itive selection because they display the self erated by a random mechanism, the im- nonlymphoid cells and their products. The peptide-MHC complexes that are recog- mune system must tolerate the function of anatomic features that are designed to op- nized by CD4+ CD8+ thymocytes and also T lymphocytes that by chance express a timize immune tolerance toward innocuous provide essential differentiation factors self-reactive antigen receptor.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]
  • Human Antigen-Specific Memory Natural Killer Cell Responses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.09.374348; this version posted November 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Human antigen-specific memory natural killer cell responses develop 2 against HIV-1 and influenza virus and are dependent on MHC-E 3 restriction 4 5 6 Stephanie Jost1, Olivier Lucar1, Taylor Yoder1, Kyle Kroll1, Sho Sugawara1, Scott Smith1, Rhianna 7 Jones1, George Tweet1, Alexandra Werner1, Phillip J. Tomezsko2, Haley L. Dugan2†, Joshua 1 3 3 4 5 8 Ghofrani , Marcus Altfeld , Adam Grundhoff , Michaela Muller-Trutwin , Paul Goepfert , R. Keith 9 Reeves1,2 * 10 11 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard 12 Medical School, Boston, MA 02115, USA; 2Ragon Institute of Massachusetts General Hospital, 13 MIT, and Harvard, Cambridge, MA 02139, USA; 3Heinrich Pette Institute, Leibniz Institute for 14 Experimental Virology, 20251 Hamburg, Germany; 4Institut Pasteur, HIV, Inflammation and 15 Persistence Unit, Paris, France; 5University of Alabama at Birmingham, Birmingham, AL 35294, 16 USA 17 18 *Corresponding author 19 R. Keith Reeves 20 Center for Virology and Vaccine Research 21 Beth Israel Deaconess Medical Center 22 3 Blackfan Circle 23 Boston, MA 02215 24 Ph: (617-735-4586) 25 Fax: (617-735-4527) 26 E-mail: [email protected] 27 28 †Current address: Committee on Immunology, University of Chicago, Chicago, IL 60637, USA 29 30 Running Title: Human Memory NK Cells 31 32 Abstract: 185 words 33 Main Text: 2713 words 34 Methods Text: 2035 words 35 5 Figures 36 7 Supplemental Figures 37 3 Supplemental Tables 38 62 references 39 40 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.09.374348; this version posted November 10, 2020.
    [Show full text]